glp 1 neurodegenerative disease A new Science Perspective highlights the growing body of evidence that hints at the potential of GLP-1–based medications in treating conditions other than diabetes and obesity, including cardiovascular and disorders GLP-1 Agonists Show Promise in

The Effect of Green Tea Supplementation on Obesity: A Systematic Review and Dose-Response Meta-Analysis of Randomized Controlled Trials

J., Jill James, S., Melnyk, S., Jernigan, S., Hubanks, A., Rose, S., & Gaylor, D

FIGURE 1 2 Phytochemical-based nanosystems for gene and tumor microenvironment targeting 2.1 Formulation challenges and delivery strategies While plant-derived drugs such as vincristine, paclitaxel, and docetaxel are established in oncology, they represent only a small fraction of phytochemicals with demonstrated preclinical anticancer activity that have yet to translate into routine clinical use (Figure 1) (Mazumder et al., 2022

Photoaging the premature structural deterioration of skin caused by ultraviolet radiation has become a major focus of peptide research

Stool transplants: ready for prime time